63 related articles for article (PubMed ID: 2886330)
1. [Conversion enzyme inhibitors in the antihypertensive treatment of patients with renal insufficiency].
Reisch C; Mann J; Ritz E
Dtsch Med Wochenschr; 1987 Aug; 112(33):1249-52. PubMed ID: 2886330
[TBL] [Abstract][Full Text] [Related]
2. Converting enzyme inhibitors and calcium antagonists in the long-term treatment of hypertension in chronic renal failure.
Lenz T; August P
Wien Klin Wochenschr; 1990 May; 102(11):315-9. PubMed ID: 2195780
[TBL] [Abstract][Full Text] [Related]
3. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
4. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
Kanno Y; Okada H; Saruta T; Suzuki H
Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796
[TBL] [Abstract][Full Text] [Related]
6. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of antihypertensive treatment in chronic renal failure: to what extent and with which drugs do patients treated by nephrologists achieve the recommended blood pressure?
Giverhaug T; Falck A; Eriksen BO
J Hum Hypertens; 2004 Sep; 18(9):649-54. PubMed ID: 15002005
[TBL] [Abstract][Full Text] [Related]
8. Managing hypertension in chronic renal disease.
Faubert PF; Porush JG
Geriatrics; 1987 Jan; 42(1):49-51, 55-8. PubMed ID: 2879773
[TBL] [Abstract][Full Text] [Related]
9. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
10. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
van Essen GG; Apperloo AJ; Rensma PL; Stegeman CA; Sluiter WJ; de Zeeuw D; de Jong PE
Kidney Int Suppl; 1997 Dec; 63():S58-62. PubMed ID: 9407423
[TBL] [Abstract][Full Text] [Related]
11. Lercanidipine in patients with chronic renal failure: the ZAFRA study.
Robles NR; Ocon J; Gomez CF; Manjon M; Pastor L; Herrera J; Villatoro J; Calls J; Torrijos J; Rodríguez VI; Rodriguez MM; Mendez ML; Morey A; Martinez FI; Marco J; Liebana A; Rincon B; Tornero F
Ren Fail; 2005; 27(1):73-80. PubMed ID: 15717638
[TBL] [Abstract][Full Text] [Related]
12. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
Román O; Cuevas G; Bunout D
Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
[TBL] [Abstract][Full Text] [Related]
13. Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors.
Kohzuki M; Kanazawa M; Liu PF; Kamimoto M; Yoshida K; Saito T; Yasujima M; Sato T; Abe K
J Hypertens; 1995 Dec; 13(12 Pt 2):1785-90. PubMed ID: 8903652
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of angiotensin converting enzyme inhibitor and calcium channel blocker in the treatment of steroid-resistant idiopathic nephrotic syndrome.
Kumar NS; Singh AK; Mishra RN; Prakash J
J Assoc Physicians India; 2004 Jun; 52():454-8. PubMed ID: 15645954
[TBL] [Abstract][Full Text] [Related]
15. [Use of angiotensin-converting enzyme inhibitors in chronic kidney insufficiency].
Kutyrina IM; Lifshits NL; Rogov VA; Kamyshova ES; Shvetsov MIu; Okonova EB; Androsova SO; Martynov SA; Miroshnichenko NG; Gerasimenko OI
Ter Arkh; 2002; 74(6):34-9. PubMed ID: 12136480
[TBL] [Abstract][Full Text] [Related]
16. [The value of angiotensin-converting enzyme inhibitors in the treatment of hypertension].
Klaus D
Z Kardiol; 1988; 77 Suppl 3():73-88. PubMed ID: 3062960
[TBL] [Abstract][Full Text] [Related]
17. [Effect of the ACE-inhibitor captopril on the blood pressure and kidney function of patients with essential and renal hypertension].
Jansa U; Stein G; Günther K
Z Gesamte Inn Med; 1991 Dec; 46(17):642-7. PubMed ID: 1776307
[TBL] [Abstract][Full Text] [Related]
18. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
[TBL] [Abstract][Full Text] [Related]
20. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
